BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen X, Jiang X, Cheng C, Chen J, Huang S, Xu M, Liu S. Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway. Cardiovasc Drugs Ther 2020;34:463-73. [PMID: 32394178 DOI: 10.1007/s10557-020-06977-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Huang DN, Wu FF, Zhang AH, Sun H, Wang XJ. Efficacy of berberine in treatment of rheumatoid arthritis: From multiple targets to therapeutic potential. Pharmacol Res 2021;169:105667. [PMID: 33989762 DOI: 10.1016/j.phrs.2021.105667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gu J, Chen X, Jin Y, Liu M, Xu Q, Liu X, Luo Z, Ling S, Liu N, Liu S. A Neonatal Mouse Model for Pressure Overload: Myocardial Response Corresponds to Severity. Front Cardiovasc Med 2021;8:660246. [PMID: 34095250 DOI: 10.3389/fcvm.2021.660246] [Reference Citation Analysis]
3 Xu X, Xie X, Zhang H, Wang P, Li G, Chen J, Chen G, Cao X, Xiong L, Peng F, Peng C. Water-soluble alkaloids extracted from Aconiti Radix lateralis praeparata protect against chronic heart failure in rats via a calcium signaling pathway. Biomed Pharmacother 2021;135:111184. [PMID: 33418305 DOI: 10.1016/j.biopha.2020.111184] [Reference Citation Analysis]
4 Shi X, Zhang B, Chu Z, Han B, Zhang X, Huang P, Han J. Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses. Cardiovasc Ther 2021;2021:9995342. [PMID: 34290825 DOI: 10.1155/2021/9995342] [Reference Citation Analysis]
5 Fan CL, Liang S, Ye MN, Cai WJ, Chen M, Hou YL, Guo J, Dai Y. Periplocymarin alleviates pathological cardiac hypertrophy via inhibiting the JAK2/STAT3 signalling pathway. J Cell Mol Med 2022. [PMID: 35365949 DOI: 10.1111/jcmm.17267] [Reference Citation Analysis]
6 Cai Y, Xin Q, Lu J, Miao Y, Lin Q, Cong W, Chen K. A New Therapeutic Candidate for Cardiovascular Diseases: Berberine. Front Pharmacol 2021;12:631100. [PMID: 33815112 DOI: 10.3389/fphar.2021.631100] [Reference Citation Analysis]